of patients with lung cancer both for adenocarcinoma and non-adenocarcinoma.2 The percentage of patients who had the GSTM1 gene did not differ significantly with type or grade of tumour. Most of the patients with bladder cancer (67%) were smokers or former smokers, but there was no significant difference in GSTM1 genotype frequency between these subjects and the non-smokers in the group.
No takes yet. Share an insight, caveat, or question.
Nouri et al. (1993) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: